Patents by Inventor Tina Zimmermann

Tina Zimmermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058443
    Abstract: The present invention relates to the prevention or mitigation of adverse effects related to NK cell engaging agents, such as cytokine-related infusion reactions. Specifically, the invention relates to the prevention or mitigation of such side effects using an inhibitor of Src, JAK and/or mTOR.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 22, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Hélène Cécile HAEGEL, Christian KLEIN, Gabrielle LECLERCQ, Alberto TOSO, Tina ZIMMERMANN
  • Publication number: 20220168418
    Abstract: The present invention relates to the prevention or mitigation of adverse effects related to T cell engaging agents, such as cytokine release syndrome. Specifically, the invention relates to the prevention or mitigation of such side effects using an inhibitor of JAK and/or mTOR.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 2, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Hélène Cécile HAEGEL, Christian KLEIN, Gabrielle LECLERCQ, Alberto TOSO, Tina ZIMMERMANN
  • Publication number: 20220088195
    Abstract: The present invention relates to the prevention or mitigation of adverse effects related to T cell bispecific antibodies, such as cytokine release syndrome. Specifically, the invention relates to the prevention or mitigation of such side effects using a tyrosine kinase inhibitor such as dasatinib.
    Type: Application
    Filed: September 24, 2021
    Publication date: March 24, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Christian Klein, Hélène Cécile Haegel, Alberto Toso, Gabrielle Leclercq, Tina Zimmermann
  • Publication number: 20200282075
    Abstract: The present invention relates to cargo substance-loaded, albumin-modified nanoparticles comprising a targeting ligand, to a method for producing such nanoparticles, to nanoparticles obtainable by said method, to a pharmaceutical composition containing a plurality of such nanoparticles and to the medical use of such nanoparticles.
    Type: Application
    Filed: September 6, 2018
    Publication date: September 10, 2020
    Inventors: Lance KALETA, Axel MEYER, Christian RIED, Michael ROHE, Kathrin SCHÄKER-THEOBALD, Sonja TALMON, Christopher UNTUCHT, Tina ZIMMERMANN
  • Patent number: 9335457
    Abstract: A textile fabric has at least one fabric layer with warp and weft threads and at least one light emission layer abutting onto the first fabric layer in a flat manner and is connected to this and is formed for the conduction and the emission of light. This arrangement provides a textile fabric that provides ambient illumination.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: May 10, 2016
    Assignee: Daimler AG
    Inventors: Tina Zimmermann, Hubert Bieder
  • Publication number: 20150177436
    Abstract: A textile fabric has at least one fabric layer with warp and weft threads and at least one light emission layer abutting onto the first fabric layer in a flat manner and is connected to this and is formed for the conduction and the emission of light. This arrangement provides a textile fabric that provides ambient illumination.
    Type: Application
    Filed: May 28, 2013
    Publication date: June 25, 2015
    Inventors: Tina Zimmermann, Hubert Bieder
  • Patent number: D396360
    Type: Grant
    Filed: April 14, 1997
    Date of Patent: July 28, 1998
    Assignee: Klober GmbH
    Inventor: Tina Zimmermann
  • Patent number: D419141
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: January 18, 2000
    Assignee: Silicon Graphics, Inc.
    Inventors: Daniel E. Evanicky, Tina Zimmermann, Bob Brunner